Priority Claims Cannot Be Incorporated by Reference -
In Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited, Appeal Nos. 2016-2707 and 2016-2708, the Federal Circuit held that when a patent for a...more
6/25/2018
/ Abbreviated New Drug Application (ANDA) ,
Abuse of Discretion ,
Appeals ,
Claim Construction ,
Clear Error Standard ,
Consolidated Appeals ,
Diagnostic Method ,
Disclaimers ,
Discovery ,
Extrinsic Evidence ,
Generic Drugs ,
Incorporation by Reference ,
Injunctive Relief ,
Inter Partes Review (IPR) Proceeding ,
Jurisdiction ,
Patent Infringement ,
Patent Invalidity ,
Patent Terms ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Priority Patent Claims ,
Privity of Contract ,
Product of Nature Doctrine ,
Real Party in Interest ,
Scope of the Claim ,
Subsequent Litigation ,
Time-Barred Claims ,
Treatment Method Patents
Distribution Agreements Can Constitute Offers for Sale Under Section 102(b) -
In The Medicines Company v. Hospira, Inc., Appeal Nos. 2014-1469, 2014-1504, the Federal Circuit held that a distribution agreement qualified as...more
4/11/2018
/ Amended Complaints ,
Appeals ,
Broadest Reasonable Interpretation Standard ,
Claim Construction ,
Computer-Related Inventions ,
Direct Infringement ,
Federal Rule 12(b)(6) ,
Generic Drugs ,
Indefiniteness ,
Inter Partes Review (IPR) Proceeding ,
Motion to Dismiss ,
Obviousness ,
On-Sale Bar ,
Patent Invalidity ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Pleading Standards ,
Prior Art ,
Question of Fact ,
Question of Law ,
Remand ,
Reversal ,
Sales & Distribution Agreements ,
Section 101 ,
Standard of Review ,
Summary Judgment
“Common Sense” Alone Is Not a Sufficient Motivation to Combine References -
In In Re: Van Os, Appeal No. 2015-1975, the Federal Circuit held that the Patent Trial and Appeal Board’s reliance on intuition or common sense...more
3/9/2017
/ Appeals ,
Burden of Production ,
Divided Infringement ,
Inducements ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Product Labels ,
Remand ,
Standard of Review ,
Standing ,
Vacated
PTAB’s Final Written Decision in IPR Must Explain Its Basis for a Motivation to Combine References -
In In Re: Nuvasive, Inc., Appeal No. 2015-1670, the Federal Circuit vacated the PTAB’s obviousness finding in an IPR,...more
2/18/2017
/ Appeals ,
Claim Construction ,
Divided Infringement ,
Doctrine of Equivalents ,
Evidence ,
Induced Infringement ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Reversal